CHOROIDEREMIA

Clinical trials for CHOROIDEREMIA explained in plain language.

Never miss a new study

Get alerted when new CHOROIDEREMIA trials appear

Sign up with your email to follow new studies for CHOROIDEREMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Experimental eye injection offers hope for those losing sight to rare genetic diseases

Disease control Recruiting now

This early-stage study is testing the safety and tolerability of an experimental drug called KIO-301, which is injected directly into the eye. It aims to help adults aged 18-80 with severe vision loss from genetic eye diseases like retinitis pigmentosa and choroideremia. The main…

Matched conditions: CHOROIDEREMIA

Phase: PHASE1, PHASE2 • Sponsor: Kiora Pharmaceuticals, Inc. • Aim: Disease control

Last updated Mar 25, 2026 14:07 UTC

CHOROIDEREMIA

Get alerted when new CHOROIDEREMIA trials appear

Experimental eye injection offers hope for those losing sight to rare genetic diseases